| Nome |
# |
|
The evolving role of microsatellite instability in colorectal cancer: A review, file e31e124d-490b-987f-e053-3705fe0a095a
|
2.905
|
|
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?, file e31e124d-b6eb-987f-e053-3705fe0a095a
|
987
|
|
The Italian Rare Pancreatic Exocrine Cancer Initiative, file e31e124d-b0ed-987f-e053-3705fe0a095a
|
666
|
|
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis, file e31e124d-b768-987f-e053-3705fe0a095a
|
649
|
|
Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale, file e31e124d-b6ff-987f-e053-3705fe0a095a
|
611
|
|
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial, file e31e124d-4980-987f-e053-3705fe0a095a
|
470
|
|
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol, file e31e124d-b766-987f-e053-3705fe0a095a
|
470
|
|
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences., file e31e124d-7fae-987f-e053-3705fe0a095a
|
440
|
|
Multimodal treatment of resectable pancreatic ductal adenocarcinoma, file e31e124d-b6fc-987f-e053-3705fe0a095a
|
416
|
|
Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going, file e31e124d-13b9-987f-e053-3705fe0a095a
|
401
|
|
Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib, file e31e124d-b994-987f-e053-3705fe0a095a
|
377
|
|
Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma, file e31e124d-b076-987f-e053-3705fe0a095a
|
367
|
|
Quality of life and anxious-depressive symptoms in cancer patients undergoing mindfulness-based interventions: Feasibility and preliminary outcomes on prospective single-centre case-control study (MIND4ME St.), file e31e124c-d895-987f-e053-3705fe0a095a
|
294
|
|
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target, file e31e124d-490d-987f-e053-3705fe0a095a
|
273
|
|
Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization, file e31e124f-4ad5-987f-e053-3705fe0a095a
|
263
|
|
Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?, file e31e124c-3152-987f-e053-3705fe0a095a
|
262
|
|
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer, file e31e124d-9653-987f-e053-3705fe0a095a
|
241
|
|
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial, file e31e124d-497a-987f-e053-3705fe0a095a
|
240
|
|
Predictive role of haemoglobin on disease response to neoadjuvant chemotherapy in breast cancer., file e31e124d-2167-987f-e053-3705fe0a095a
|
227
|
|
Il trattamento di prima e seconda linea nel carcinoma gastrico, file e31e124d-4914-987f-e053-3705fe0a095a
|
226
|
|
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma, file e31e124d-d79f-987f-e053-3705fe0a095a
|
213
|
|
Cancer Treatment Induced Bone Loss (CTIBL) in breast cancer women: a multidisciplinary approach at the Modena Cancer Center screening over 600 patients., file e31e124d-83c2-987f-e053-3705fe0a095a
|
212
|
|
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors, file e31e124d-497e-987f-e053-3705fe0a095a
|
193
|
|
A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC), file e31e124e-af52-987f-e053-3705fe0a095a
|
193
|
|
The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO), file e31e124d-4195-987f-e053-3705fe0a095a
|
191
|
|
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus, file e31e124d-734b-987f-e053-3705fe0a095a
|
191
|
|
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials, file e31e124d-b7df-987f-e053-3705fe0a095a
|
178
|
|
BRAF
,NRASandC-KITAdvanced Melanoma: Clinico-pathological Features, Targeted-Therapy Strategies and Survival, file e31e124e-b40e-987f-e053-3705fe0a095a
|
175
|
|
GD2 expression in breast cancer., file e31e124c-b26e-987f-e053-3705fe0a095a
|
173
|
|
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib, file e31e124d-c0ca-987f-e053-3705fe0a095a
|
162
|
|
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New, file e31e124d-ba98-987f-e053-3705fe0a095a
|
161
|
|
Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier), file e31e124d-b0ea-987f-e053-3705fe0a095a
|
160
|
|
Male mammary myofibroblastoma: Two case reports and brief review of literature, file e31e124e-6149-987f-e053-3705fe0a095a
|
155
|
|
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: A retrospective study, file e31e124d-b764-987f-e053-3705fe0a095a
|
151
|
|
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy., file e31e124d-f9c8-987f-e053-3705fe0a095a
|
150
|
|
Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs), file e31e124f-04db-987f-e053-3705fe0a095a
|
141
|
|
Neutrophil-to-lymphocyte ratio may be associated with the outcome in patients with prostate cancer, file e31e124c-5019-987f-e053-3705fe0a095a
|
140
|
|
Endocrine sensitive metastatic breast cancer and bone only disease: are the new treatments always better?, file e31e124d-83c0-987f-e053-3705fe0a095a
|
140
|
|
The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer, file e31e124d-b777-987f-e053-3705fe0a095a
|
140
|
|
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin, file e31e124d-b7da-987f-e053-3705fe0a095a
|
136
|
|
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial, file e31e124d-cb10-987f-e053-3705fe0a095a
|
136
|
|
eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS study, file e31e124d-b996-987f-e053-3705fe0a095a
|
132
|
|
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY), file e31e124d-33f2-987f-e053-3705fe0a095a
|
122
|
|
Immunohistochemical mismatch repair proteins expression as a tool to predict the melanoma immunotherapy response, file e31e124d-f529-987f-e053-3705fe0a095a
|
120
|
|
Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer., file e31e124d-fbc8-987f-e053-3705fe0a095a
|
120
|
|
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies, file e31e124e-0200-987f-e053-3705fe0a095a
|
116
|
|
Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients., file e31e124e-0394-987f-e053-3705fe0a095a
|
114
|
|
Progress of molecular targeted therapies for advanced renal cell carcinoma., file e31e124e-0778-987f-e053-3705fe0a095a
|
114
|
|
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management., file e31e124e-088f-987f-e053-3705fe0a095a
|
111
|
|
Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review., file e31e124f-232b-987f-e053-3705fe0a095a
|
110
|
|
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word
experience., file e31e124d-2b94-987f-e053-3705fe0a095a
|
109
|
|
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach., file e31e124e-0327-987f-e053-3705fe0a095a
|
105
|
|
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations., file e31e124e-01ff-987f-e053-3705fe0a095a
|
104
|
|
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management, file e31e124e-0e38-987f-e053-3705fe0a095a
|
104
|
|
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab., file e31e124e-07d9-987f-e053-3705fe0a095a
|
103
|
|
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients., file e31e124e-0003-987f-e053-3705fe0a095a
|
97
|
|
Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer., file e31e124d-2a58-987f-e053-3705fe0a095a
|
93
|
|
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy, file e31e124e-ad60-987f-e053-3705fe0a095a
|
92
|
|
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy, file e3f34582-b9bf-4ecc-8b49-a226d9a10de8
|
92
|
|
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy, file e31e124e-bc3b-987f-e053-3705fe0a095a
|
91
|
|
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials., file e31e124f-d99a-987f-e053-3705fe0a095a
|
88
|
|
First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?, file e31e124d-7d97-987f-e053-3705fe0a095a
|
82
|
|
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer, file e31e124e-2cbd-987f-e053-3705fe0a095a
|
80
|
|
M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer, file e31e124f-b75a-987f-e053-3705fe0a095a
|
77
|
|
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus., file e31e124d-283e-987f-e053-3705fe0a095a
|
70
|
|
Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue, file e31e124f-4010-987f-e053-3705fe0a095a
|
70
|
|
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status, file e31e124c-f954-987f-e053-3705fe0a095a
|
66
|
|
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation, file e31e124f-7b00-987f-e053-3705fe0a095a
|
66
|
|
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status., file e31e124d-28b2-987f-e053-3705fe0a095a
|
57
|
|
Role of maspin in cancer., file e31e124e-2634-987f-e053-3705fe0a095a
|
54
|
|
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial, file e31e124d-cb13-987f-e053-3705fe0a095a
|
45
|
|
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases ., file e31e124d-83be-987f-e053-3705fe0a095a
|
36
|
|
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients., file e31e124d-d296-987f-e053-3705fe0a095a
|
23
|
|
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients ., file e31e124d-7fd5-987f-e053-3705fe0a095a
|
18
|
|
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery, file 3c5d8cae-da6b-4ee7-b083-287a80a4545b
|
15
|
|
BRAF-mutated colorectal cancer: Clinical and molecular insights, file c3dd0d75-348d-4d6b-8cc5-65beb02f952d
|
8
|
|
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Protein in Urothelial Cell Carcinoma of Human Bladder, file 3d1dedca-0333-406f-ac23-32589799ab31
|
7
|
|
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma, file 2184008d-46cd-4b57-8ecf-e7083bddcdd0
|
6
|
|
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinoma, file 40c893da-8abe-4169-9a4e-447f7e023428
|
6
|
|
Occult breast cancer: the uncommon presentation of a common disease, file 74edb288-c5cc-44c5-9fa1-434b92160351
|
6
|
|
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer, file 7b1b391a-b88d-4790-a792-e5bc1a03b7cb
|
6
|
|
Pazopanib and sunitinib trigger autophagic and non autophagic death of bladder tumor cells., file 69feaa4d-a496-4413-b2aa-987b0ffa008a
|
5
|
|
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib, file 8ac1c8bb-5814-45d5-b6a2-e4b1e9bd0f04
|
5
|
|
[11C]-Methionine Positron Emission Tomography in the Postoperative Imaging and Followup of Patients with Primary and Recurrent Gliomas, file b39a6ef3-09c2-47fb-b6bb-447f19ec4a30
|
5
|
|
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients, file e31e124c-048f-987f-e053-3705fe0a095a
|
5
|
|
The Role of Anti-Angiogenics in Pre-Treated Metastatic BRAF-Mutant Colorectal Cancer: A Pooled Analysis, file 44d74c39-8c6f-4e03-988c-309f7a6da3d3
|
3
|
|
Pre-treatment neutrophil to lymphocyte ratio as an independent prognostic factor in patients with treated with everolimus for metastatic renal cell carcinoma, file 558bacb4-909e-4e97-87b3-5f7da6a9c17d
|
3
|
|
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients., file 103838cd-d034-462f-a7ae-fbda8ea37ed5
|
2
|
|
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy, file ab988840-6bda-4418-934b-c54980995d2f
|
2
|
|
Dabrafenib-trametinib combination in 'field-practice': An Italian experience, file e31e124e-9ab9-987f-e053-3705fe0a095a
|
2
|
|
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis, file e31e124e-f3ca-987f-e053-3705fe0a095a
|
2
|
|
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review, file e31e124f-6bd2-987f-e053-3705fe0a095a
|
2
|
|
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor., file 12ec448c-3c7b-42f8-bb98-7ba764f6f13c
|
1
|
|
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, file 86798704-86d5-4851-8107-347f32a002af
|
1
|
|
Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid., file e31e124c-aba0-987f-e053-3705fe0a095a
|
1
|
|
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach?, file e31e124f-48be-987f-e053-3705fe0a095a
|
1
|
|
Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus, file e31e124f-639d-987f-e053-3705fe0a095a
|
1
|
|
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients, file e31e124f-a8ef-987f-e053-3705fe0a095a
|
1
|
|
Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain, file e31e124f-c720-987f-e053-3705fe0a095a
|
1
|
| Totale |
17.254 |
